Ronald J. Vagnozzi, Ph.D.
Affiliations: | 2013 | Cell and Developmental Biology | Thomas Jefferson University, Philadelphia, PA, United States |
Area:
Cell Biology, Molecular Biology, PathologyGoogle:
"Ronald Vagnozzi"Parents
Sign in to add mentor| Thomas L. Force | grad student | 2013 | Thomas Jefferson | |
| (Cardiac Troponin I-interacting Kinase (TNNI3K/CARK) Adversely Regulates Injury, Cell Death and Oxidative Stress in the Ischemic Heart.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Baldwin TA, Teuber JP, Kuwabara Y, et al. (2023) Palmitoylation-Dependent Regulation of Cardiomyocyte Rac1 Signaling Activity and Minor Effects on Cardiac Hypertrophy. The Journal of Biological Chemistry. 105426 |
| Alexanian M, Padmanabhan A, Nishino T, et al. (2023) Chromatin Remodeling Drives Immune-Fibroblast Crosstalk in Heart Failure Pathogenesis. Biorxiv : the Preprint Server For Biology |
| McKinsey TA, Foo R, Anene-Nzelu CG, et al. (2022) Emerging epigenetic therapies of cardiac fibrosis and remodeling in heart failure: from basic mechanisms to early clinical development. Cardiovascular Research |
| Vagnozzi RJ, Kasam RK, Sargent MA, et al. (2021) Cardiac Cell Therapy Fails to Rejuvenate the Chronically Scarred Rodent Heart. Circulation. 144: 328-331 |
| Vagnozzi RJ, Molkentin JD. (2020) Resident macrophages keep mitochondria running in the heart. Cell Research |
| Vagnozzi RJ, Sargent MA, Molkentin JD. (2020) Cardiac Cell Therapy Rejuvenates the Infarcted Rodent Heart via Direct Injection but Not by Vascular Infusion. Circulation. 141: 1037-1039 |
| Kim AJ, Xu N, Umeyama K, et al. (2020) Deficiency of Circulating Monocytes Ameliorates the Progression of Myxomatous Valve Degeneration in Marfan Syndrome. Circulation. 141: 132-146 |
| Vagnozzi RJ, Maillet M, Sargent MA, et al. (2019) An acute immune response underlies the benefit of cardiac stem-cell therapy. Nature |
| Vagnozzi RJ, Johansen AKZ, Molkentin JD. (2019) CARdiac Immunotherapy: T Cells Engineered to Treat the Fibrotic Heart. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Khalil H, Kanisicak O, Vagnozzi RJ, et al. (2019) Cell-specific ablation of Hsp47 defines the collagen-producing cells in the injured heart Jci Insight. 4: e128722 |